For the 15th year in a row, UC San Francisco garnered the top spot among public institutions in funding from the National Institutes of Health (NIH) in 2021. UCSF continued to rank highly among all public and private institutions nationwide, ranking fourth overall.
The University was awarded nearly 1,500 NIH grants and contracts, amounting to more than $709 million in funds – a $23 million increase from the 2020 total and a new record for NIH funding to a public university.
The highly competitive funds represent awards and contracts to the UCSF Schools of Dentistry, Medicine, Nursing and Pharmacy, as well as the Graduate Division, during the 2021 fiscal year that ended in September. They support UCSF scientists in their efforts to understand the causes of, and discover treatments for, diseases ranging from cancer to diabetes to neurodegenerative diseases. In the past year, NIH funding continued to provide critical support for COVID-19 research amid the ongoing pandemic.
“This NIH funding has helped UCSF researchers gain new fundamental insights in biology, develop new therapies for intractable diseases, and address
